medigraphic.com
ISSN 2221-2434 (Electronic)

2014, Number 2

<< Back Next >>

Finlay 2014; 4 (2)

Effectiveness of Heberprot P for diabetic foot ulcer in a health area

Mass BGM, Cabrera RT, Torres TFA, Vidal CG, Moya ÁA, Alonso AJA

Language: Spanish
References: 14
Page: 85-89
PDF size: 100.33 Kb.


ABSTRACT

Background: many papers on the effectiveness of Heberprot P in granulation and healing of diabetic foot ulcer in outpatient settings have been published, but very few stem from Primary Health Care.
Objective: to evaluate the therapeutic effectiveness of Herberprot P in patients with diabetic foot ulcer.
Methods: a descriptive, case series study was conducted in 15 patients with diabetic foot treated with Herberprot P in the Area IV Community Teaching Polyclinic from January to December 2012. Variables analyzed were age, sex, clinical classification of the disease and classification and evolution of the lesion.
Results: diabetic foot ulcer was more frequent in patients aged 60-69 years, predominantly females. Most patients were diagnosed with neuroinfectious diabetic foot, and the most frequent lesion was deep ulcer, developed by 9 patients. Complete healing was observed in 11 patients, 6 of them in a period of 20-30 days.
Conclusion: results show, and especially confirm the effectiveness of Heberprot P in the treatment of patients with diabetic foot ulcer in Primary Health Care.


REFERENCES

  1. Chan M. Alocución a la 65.ª Asamblea Mundial de la Salud [Internet]. Ginebra: OMS; 2012. [ cited 22 Ene 2014 ] Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A6 5_3-sp.pdf.

  2. Ministerio de Salud Pública. Anuario Estadístico de Salud 2012 [Internet]. La Habana: Dirección Nacional de Estadísticas; 2012. [ cited Sep 2013 ] Available from: http://files.sld.cu/dne/files/2013/04/anuario_2012. pdf.

  3. OMS. Qué es la diabetes [Internet]. Ginebra: OMS; 2014. [ cited 22 Ene 2014 ] Available from: http://www.who.int/diabetes/action_online/basics/ es/index3.html.

  4. Rincón Y, Gil V, Pacheco J, Benítez I, Sánchez M. Evaluación y tratamiento del pie diabético. Rev Venez Endocrinol Metab. 2012 ; 10 (3): 176-87.

  5. Fernández J, Sancho N, Fleitas E, Santiesteban Ll. El Heberprot P como indicación terapéutica en el tratamiento curativo de las úlceras por presión. Revista española de investigaciones quirúrgicas. 2011 ; 14 (3): 143-5.

  6. Álvarez AR, Alonso L, Yera I, García AJ. Evolución clínica de pacientes con úlcera del pie diabético tratados con Heberprot-P®. AMC [revista en Internet]. 2013 [ cited 12 Feb 2014 ] ; 17 (5): [aprox. 11p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1025-02552013000500004&lng=es.

  7. Junco DA, Moncada O, Montoya LE, Blanco F, Hernández JC. Eficacia del Heberprot-P® en el tratamiento de las úlceras del pie diabético. MEDISAN [revista en Internet]. 2012 [ cited 12 Feb 2014 ] ; 16 (11): [aprox. 8p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1029-30192012001100007&lng=es.

  8. Martínez P, Aguilera M. Impacto del uso del Heberprot-P en el municipio Cacocum en 2012. CCM [revista en Internet]. 2013 [ cited 12 Feb 2014 ] ; 17 (2): [aprox. 3p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1560-43812013000200025&lng=es.

  9. Baldomero JE, Silva R, Herrera L, López P, del Río A, Saurí JE, et al. Implementation of an integral health program for diabetic foot ulcer patients by using Heberprot-P at the primary health attention level in the municipality of Playa, in Havana, Cuba. Biotecnol Apl [revista en Internet]. 2010 [ cited 12 Feb 2014 ] ; 27 (2): [aprox. 3p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1027-28522010000200010&lng=es.

  10. Martínez R, Montano E, Pérez D, Torres O, Tejera JF, González L. Non-surgical but efficacious technique for diabetic foot treatment. Biotecnol Apl [revista en Internet]. 2010 [ cited 12 Feb 2014 ] ; 27 (2): [aprox. 6p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1027-28522010000200006&lng=es.

  11. Fernández JI, Mena G, Santiesteban L. Treatment and recovery of Wagner 5 diabetic foot with Heberprot-P. Biotecnol Apl [revista en Internet]. 2010 [ cited 12 Feb 2014 ] ; 27 (2): [aprox. 10p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1027-28522010000200005&lng=es.

  12. Ocampo P, Landeros D, Méndez LR. Frecuencia de depresión en pacientes con y sin pie diabético. Semergen [revista en Internet]. 2010 [ cited 10 Nov 2013 ] ; 36 (9): [aprox. 13p]. Available from: http://zl.elsevier.es/es/revista/semergen-medicin a-general-familia-40/articulo/frecuencia-depresio n-pacientes-con-sin-13184354?referer=buscador.

  13. Hernández MJ, Llanes JA, Acosta DS. Heberprot P, una terapia eficaz en la prevención de la amputación del pie diabético. Revista Cubana de Angiología y Cirugía Vascular [revista en Internet]. 2009 [ cited 10 Nov 2013 ] ; 10 (1): [aprox. 14p]. Available from: http://www.bvs.sld.cu/revistas/ang/vol10_1_09/an g02109.pdf.

  14. Rivero FE. Experiencias del Programa de atención integral a pacientes con pie diabético en el estado Zulia, Venezuela. Biotecnol Apl [revista en Internet]. 2010 [ cited 10 Nov 2013 ] ; 27 (2): [aprox. 16p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1027-28522010000200004&lng=es.




2020     |     www.medigraphic.com